The pharmaceutical excipients market involves manufacturing various products such as fillers, binders, coatings, diluents, disintegrants, solvents, lubricants, and flavors that are used as inactive ingredients along with the active pharmaceutical ingredients (APIs) in drug formulations and medicines. They play an important role in oral drug delivery by improving the mechanical properties of tablets and capsules and modifying drug release during dissolution. The market has witnessed significant growth over the past few years due to various advantages offered by excipients such as improved bioavailability and stability of APIs, better mouthfeel and taste masking, and capability to suit needs of different dosage forms.

The global pharmaceutical excipients market is estimated to be valued at US$ 12.33 Mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Global Pharmaceutical Excipients Market Size are Waters Corporation, Agilent Technologies Inc., Bruker Corporation, SCIEX, Shimadzu, Danaher, Thermo Fisher Scientific Inc., Shimadzu, and PerkinElmer Inc. These companies have extensive experience in developing innovative excipient solutions and technologies along with geographic expansion and merger & acquisition activities to consolidate market presence.

The pharmaceutical excipients market is witnessing significant growth owing to increasing demand from generics market across the globe. As many blockbuster drug patents expire, generics manufacturers are launching their copies of branded formulations at much lower costs, thus driving excipients requirement. Further, growing prevalence of chronic lifestyle diseases and aging population has enhanced global pharmaceutical sales, supplementing excipients consumption.

Advancements in drug delivery technologies have opened up opportunities for innovation in excipients field. Novel technologies such as hot-melt extrusion, spray-drying, nanoparticle engineering, and 3D printing offer ways to develop functional excipients for controlled/targeted release applications. Companies are investing heavily in R&D to introduce platform technologies and differentiated solutions.

Market Trends

- Multi-functional excipients: Excipient manufacturers are focusing on developing multi-functional formulations that can replace combinations of individual excipients. This reduces costs and complexity in drug development.

- Sustainable excipients: With growing emphasis on environmental sustainability, naturally-derived and green excipients prepared from renewable resources are gaining traction in the industry.

Market Opportunities

- Developing markets: Emerging Asian, Latin American, Middle Eastern and African countries present significant untapped opportunities for excipient sales owing to rapid economic development and rising healthcare spends.

- Complex generics formulations: Upcoming patent cliff of blockbuster biologics will require complex formulation technologies involving novel excipients. This presents lucrative opportunities for excipient innovators.

Impact of COVID-19 on Pharmaceutical Excipients Market Growth

The COVID-19 pandemic has significantly impacted the growth of the pharmaceutical excipients market. During the initial months of the crisis, countries worldwide imposed strict lockdowns and social distancing measures to curb the spread of the virus. This disrupted global supply chains and manufacturing activities. There was a shortage of active pharmaceutical ingredients (APIs) and other key materials. This challenged the production of various drugs requiring excipients.

However, with time, the market has gradually adapted to the new normal. Manufacturers have implemented new safety protocols and optimized production workflows to ensure business continuity while protecting worker health. Furthermore, the pandemic has highlighted the importance of a strong pharmaceutical supply chain. It has driven increased government investments and policy support for the domestic production of essential medicines. This is positively influencing the long-term outlook of the excipients industry.

The demand for antiviral drugs, vaccines and therapeutics for COVID-19 treatment has provided a new growth avenue. Various clinical trials are ongoing to develop effective medications against the coronavirus. This R&D activity involves extensive formulation and testing requiring different types of excipients. Hence, the excipients market is expected to witness steady growth through the forecast period backed by pandemic preparedness programs worldwide.

Geographical Regions with High Pharmaceutical Excipients Market Concentration
North America is one of the most concentrated markets for pharmaceutical excipients in terms of value. The region is home to many leading pharmaceutical companies with well-established R&D and manufacturing infrastructure. This supports robust demand for various excipients from the drug development and production activities. Furthermore, North American countries, especially the US, spend heavily on healthcare and medicines. This favors the regional excipients industry.

Another region with high market concentration is Western Europe. Countries like Germany, France, UK and Italy have strong pharmaceutical sectors and regulatory frameworks conducive for pharmaceutical formulation development and manufacturing. Major international excipient suppliers have production facilities located within Europe to ensure timely supply for the local pharmaceutical companies. The presence of advanced healthcare systems further augments excipient consumption across Western European nations.

Fastest Growing Regional Market for Pharmaceutical Excipients

The Asia Pacific region is projected to be the fastest growing market for pharmaceutical excipients over the forecast period. With improving accessibility and rising healthcare expenditures, the demand for medicines is increasing rapidly throughout the developing Asia Pacific economies. International pharmaceutical companies are aggressively expanding outsourced drug manufacturing activities to the low-cost countries in the region including India and China. This is translating to greater investment into excipient production and imports as well. Developments like these are fueling the fastest gains for the pharmaceutical excipients market in Asia Pacific. Meanwhile, growing local pharmaceutical industries are also bolstering regional excipient usage for their formulation needs.

Get More Insights On This Topic: https://www.pressreleasebulletin.com/pharmaceutical-excipients-market-forecast-outlook-trend-2023-2030/